Satisfaction with care: Average endpoint score (CAT, high = good) · patients with schizophrenia
1 finding from 1 review
Quality of Life Manchester Short Assessment (MANSA) · patients with schizophrenia
1 finding from 1 review
Global state: clinically important change in global state · people with the acute phase of schizophrenia
It is very uncertain whether magnetic seizure therapy plus standard care changes global state: clinically important change assessed by: number of… compared with electroconvulsive therapy plus standard care (very low certainty).
1 finding from 1 review
Cognitive functioning: clinically important change ‐ not measured · people with the acute phase of schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects: clinically important adverse effectsassessed by: number of participants with a delayed memory deficitStudy duration: 4 weeks · people with the acute phase of schizophrenia
It is very uncertain whether magnetic seizure therapy plus standard care changes adverse effects: clinically important adverse effectsassessed by:… compared with electroconvulsive therapy plus standard care (very low certainty).
1 finding from 1 review
Quality of life: clinically important change ‐ not measured · people with the acute phase of schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Social functioning: clinically important change ‐ not measured · people with the acute phase of schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dropout · people with the acute phase of schizophrenia
It is very uncertain whether magnetic seizure therapy plus standard care changes leaving the study early: any reasonassessed by: number of dropouts… compared with electroconvulsive therapy plus standard care (very low certainty).
1 finding from 1 review
Mental state: 2. Positive symptoms ‐ average endpoint score PANSS positive subscore · schizophrenia or related disorders
1 finding from 1 review
Global state: relapse (rehospitalised) · schizophrenia or related disorders
1 finding from 1 review
Behaviour: Leaving the study early (short‐term) · schizophrenia or related disorders
Avatar Therapy probably leads to higher leaving study early: for any reason – short term compared with supportive counselling (all short‐term) (moderate certainty).
1 finding from 1 review
Anxiety (adverse effect, post‐intervention) · schizophrenia or related disorders
1 finding from 1 review
Quality of Life Manchester Short Assessment (MANSA) · schizophrenia or related disorders
1 finding from 1 review
Functioning: clinically important change · schizophrenia or related disorders
1 finding from 1 review
Mental state: specific – insight – average attitude to voices score (BAVQ‐R, high = poor) – short term · schizophrenia or related disorders
1 finding from 1 review
Global state: relapse (rehospitalised) – short term · schizophrenia or related disorders
Avatar Therapy showed no clear difference in global state: relapse (rehospitalised) – short term compared with treatment (low certainty).
1 finding from 1 review
Leaving the study early · schizophrenia or related disorders
Avatar Therapy showed no clear difference in leaving study early: for any reason compared with treatment (low certainty).
1 finding from 1 review
Adverse events – anxiety – after first session – short term · schizophrenia or related disorders
Avatar Therapy showed no clear difference in adverse events – anxiety – after first session – short term compared with treatment (low certainty).
1 finding from 1 review
QoL · schizophrenia or related disorders
1 finding from 1 review
Functioning: clinically important change · schizophrenia or related disorders
1 finding from 1 review